The digital health space saw seven ‘unicorn’ companies, or private companies valued at more than $1 billion, exit. The exit activity, which is when the company goes public or is acquired, nearly doubled the four exits in 2019 and two exits in 2018.
Here are the seven digital health unicorns that exited in 2020 as well as their valuations:
- GoodRx: $12.7 billion
- Grail: $8 billion
- Gan & Lee: $3.6 billion
- Cure Vac: $2.8 billion
- One Medical: $1.7 billion
- Hims & Hers $1.6 billion
- Butterfly: $1.5 billion
More articles on digital transformation:
Online symptom checkers can lead to delayed treatment for serious conditions: study
Apple, Harvard team up on menstrual symptom study
Fast Company’s 10 most innovative health tech companies of 2021
